The North America chlorpheniramine maleate market was valued at USD 514.9 million in 2023 and is poised for substantial growth over the forecast period from 2024 to 2032. This growth is largely driven by the rising prevalence of allergic conditions, with the market expected to grow at a compound annual growth rate (CAGR) of 5.7%, […]
Read More